Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

Research output: Contribution to journalReview articlepeer-review

170 Scopus citations

Fingerprint

Dive into the research topics of 'Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences